{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:44:57Z","timestamp":1773279897467,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T00:00:00Z","timestamp":1513036800000},"content-version":"vor","delay-in-days":102,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.livres.2017.12.001","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T03:50:02Z","timestamp":1513137002000},"page":"174-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Recent development and gene therapy for glycogen storage disease type Ia"],"prefix":"10.1016","volume":"1","author":[{"given":"Janice Y.","family":"Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goo-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ho","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2017.12.001_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/1566524024605798","article-title":"Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex","volume":"2","author":"Chou","year":"2002","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.livres.2017.12.001_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nrendo.2010.189","article-title":"Glycogen storage disease type I and G6Pase-\u03b2 deficiency: etiology and therapy","volume":"6","author":"Chou","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.livres.2017.12.001_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10545-014-9772-x","article-title":"Type I glycogen storage diseases: disorders of the glucose-6-phosphatase\/glucose-6-phosphate transporter complexes","volume":"38","author":"Chou","year":"2015","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.livres.2017.12.001_bib4","doi-asserted-by":"crossref","first-page":"32837","DOI":"10.1074\/jbc.M201853200","article-title":"The catalytic center of glucose-6-phosphatase: His176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis","volume":"277","author":"Ghosh","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2017.12.001_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM197602192940805","article-title":"Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease","volume":"294","author":"Greene","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2017.12.001_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM198401193100306","article-title":"Cornstarch therapy in type I glycogen-storage disease","volume":"310","author":"Chen","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2017.12.001_bib7","first-page":"276","article-title":"Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature","volume":"24","author":"Labrune","year":"1997","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.livres.2017.12.001_bib8","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1007\/BF02679990","article-title":"Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I)","volume":"161","author":"Rake","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.livres.2017.12.001_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10545-005-7500-2","article-title":"Hepatocellular carcinoma in glycogen storage disease type Ia: a case series","volume":"28","author":"Franco","year":"2005","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.livres.2017.12.001_bib10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.8211187","article-title":"Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a","volume":"262","author":"Lei","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.livres.2017.12.001_bib11","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1074\/jbc.273.11.6144","article-title":"Transmembrane topology of glucose-6-phosphatase","volume":"273","author":"Pan","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2017.12.001_bib12","doi-asserted-by":"crossref","first-page":"21658","DOI":"10.1074\/jbc.273.34.21658","article-title":"Asparagine-linked oligosaccharides are localized to a luminal hydrophilic loop in human glucose-6-phosphatase","volume":"273","author":"Pan","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2017.12.001_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/humu.20772","article-title":"Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease","volume":"29","author":"Chou","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.livres.2017.12.001_bib14","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1074\/jbc.M110486200","article-title":"The molecular basis of glycogen storage disease type 1a: structure and function analysis of mutations in glucose-6-phosphatase","volume":"277","author":"Shieh","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2017.12.001_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.gene.2012.07.057","article-title":"Misdiagnosis as steatohepatitis in a family with mild glycogen storage disease type 1a","volume":"509","author":"Shieh","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.livres.2017.12.001_bib16","doi-asserted-by":"crossref","first-page":"11882","DOI":"10.1074\/jbc.270.20.11882","article-title":"Structure-function analysis of human glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a","volume":"270","author":"Lei","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2017.12.001_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1096-8628(20000313)91:2<107::AID-AJMG5>3.0.CO;2-Y","article-title":"Glycogen storage disease type Ia: molecular diagnosis of 51 Japanese patients and characterization of slicing mutations by analysis of ectopically transcribed mRNA from lymphoblastoid cells","volume":"91","author":"Akanuma","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.livres.2017.12.001_bib18","first-page":"549","article-title":"Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in Japan","volume":"57","author":"Kajihara","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.livres.2017.12.001_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1399-0004.1997.tb02449.x","article-title":"Identification of a point mutation (G727T) in the glucose-6-phosphatase gene in Japanese patients with glycogen storage disease type 1a, and carrier screening in healthy volunteers","volume":"51","author":"Okubo","year":"1997","journal-title":"Clin Genet"},{"key":"10.1016\/j.livres.2017.12.001_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ajmg.a.30232","article-title":"Mutation frequencies for glycogen storage disease Ia in the Ashkenazi Jewish population","volume":"129A","author":"Ekstein","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"Suppl 1","key":"10.1016\/j.livres.2017.12.001_bib21","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1007\/BF02679989","article-title":"Glycogen storage disease type I: diagnosis and phenotype\/genotype correlation","volume":"161","author":"Matern","year":"2002","journal-title":"Eur J Pediat"},{"key":"10.1016\/j.livres.2017.12.001_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ng0696-203","article-title":"Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse","volume":"13","author":"Lei","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.livres.2017.12.001_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1006\/bmme.1997.2600","article-title":"Isolation and nucleotide sequence of canine glucose-6-phosphatase mRNA: identification of mutation in puppies with glycogen storage disease type 1a","volume":"61","author":"Kishnani","year":"1997","journal-title":"Biochem Mol Med"},{"key":"10.1016\/j.livres.2017.12.001_bib24","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/dvg.20538","article-title":"Generation of mice with a conditional allele for G6pc","volume":"47","author":"Peng","year":"2009","journal-title":"Genesis"},{"key":"10.1016\/j.livres.2017.12.001_bib25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2010.08.014","article-title":"Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas","volume":"54","author":"Mutel","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2017.12.001_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/156652307780363152","article-title":"Gene therapy for type I glycogen storage diseases","volume":"7","author":"Chou","year":"2007","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.livres.2017.12.001_bib27","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1517\/14712598.2011.578067","article-title":"Recombinant AAV-directed gene therapy for type I glycogen storage diseases","volume":"11","author":"Chou","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.livres.2017.12.001_bib28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1242\/dmm.014878","article-title":"Development of hepatocellular adenomas and carcinomas in mice with liver-specific G6Pase-\u03b1 deficiency","volume":"7","author":"Resaz","year":"2014","journal-title":"Dis Model Mech."},{"key":"10.1016\/j.livres.2017.12.001_bib29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ki.2014.102","article-title":"Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy","volume":"86","author":"Clar","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.livres.2017.12.001_bib30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10545-014-9761-0","article-title":"Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease","volume":"38","author":"Rajas","year":"2015","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.livres.2017.12.001_bib31","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood-2002-04-1260","article-title":"Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease","volume":"100","author":"Weinstein","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.livres.2017.12.001_bib32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.22995","article-title":"Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience","volume":"50","author":"Bioulac-Sage","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2017.12.001_bib33","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/j.gastro.2016.11.042","article-title":"Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation","volume":"152","author":"Nault","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2017.12.001_bib34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jhep.2012.09.030","article-title":"Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I","volume":"58","author":"Calderaro","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2017.12.001_bib35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cytogfr.2015.07.010","article-title":"Mutations leading to constitutive active gp130\/JAK1\/STAT3 pathway","volume":"26","author":"Pilati","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.livres.2017.12.001_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ymgme.2017.01.003","article-title":"Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-\u03b1 activity restored are at risk of developing hepatic tumors","volume":"120","author":"Kim","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.livres.2017.12.001_bib37","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1074\/jbc.275.2.828","article-title":"Correction of glycogen storage disease type 1a in a mouse model by gene therapy","volume":"275","author":"Zingone","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2017.12.001_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/gt.2011.86","article-title":"Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia","volume":"19","author":"Crane","year":"2012","journal-title":"Gene Ther"},{"key":"10.1016\/j.livres.2017.12.001_bib39","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/sj.gt.3302473","article-title":"Newborn liver gene transfer by an HIV-2-based lentiviral vector","volume":"12","author":"Salani","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.livres.2017.12.001_bib40","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/mt.2010.119","article-title":"Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus based vector","volume":"18","author":"Grinshpun","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.livres.2017.12.001_bib41","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/hmg\/ddu746","article-title":"Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice","volume":"24","author":"Clar","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.livres.2017.12.001_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.gt.3302650","article-title":"Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer","volume":"13","author":"Ghosh","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.livres.2017.12.001_bib43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/mt.2008.15","article-title":"AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia","volume":"16","author":"Koeberl","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.livres.2017.12.001_bib44","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/mt.2010.64","article-title":"Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy","volume":"18","author":"Yiu","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.livres.2017.12.001_bib45","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/hep.25717","article-title":"Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy","volume":"56","author":"Lee","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2017.12.001_bib46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2013.06.014","article-title":"The Upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in\u00a0murine glycogen storage disease type Ia","volume":"110","author":"Lee","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.livres.2017.12.001_bib47","first-page":"28","article-title":"Mansfield BC, Chou JY. Minimal hepatic glucose-6-phosphatase-\u03b1 activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia","volume":"3","author":"Lee","year":"2015","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.livres.2017.12.001_bib48","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1128\/JVI.00878-06","article-title":"The 37\/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9","volume":"80","author":"Akache","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.livres.2017.12.001_bib49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0065-2660(09)67002-4","article-title":"Adeno-associated viral vectors and their redirection to cell-type specific receptors","volume":"67","author":"Michelfelder","year":"2009","journal-title":"Adv Genet"},{"key":"10.1016\/j.livres.2017.12.001_bib50","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.livres.2017.12.001_bib51","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/mt.2010.71","article-title":"Combined paracrine and endocrine AAV9 mediated expression of hepatocyte growth factor for the treatment of renal fibrosis","volume":"18","author":"Schievenbusch","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.livres.2017.12.001_bib52","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gt.2014.35","article-title":"rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study","volume":"21","author":"Rocca","year":"2014","journal-title":"Gene Ther"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568417000496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568417000496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:41:46Z","timestamp":1762872106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568417000496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2542568417000496"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2017.12.001","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent development and gene therapy for glycogen storage disease type Ia","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2017.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Third Affiliated Hospital of Sun Yat-sen University. Publishing Services by Elsevier B. V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}